Answers are grounded in this paper and cite their sources.
Coronavirus disease 2019 (COVID-19) has devastated the global community since the emergence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in late 2019. Most COVID-19 cases occur in adults, and a subset develop COVID-19-associated hyperinflammatory syndrome (1), resulting in progressive respiratory illness and multiorgan dysfunction. Progression to severe COVID-19 after SARS-CoV-2 exposure is less common in young adults and children. However, since March 2020, areas with high community SARS-CoV-2 transmission have reported increasing cases of a pediatric inflammatory syndrome that occurs weeks to months after initial asymptomatic or mild SARS-CoV-2 infection (2). The US CDC termed this condition multisystem inflammatory syndrome in children (MIS-C, also known as pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 [PIMS-TS] in Europe, where it was first recognized). Since June 2020, a similar syndrome (MIS-A) has been recognized in adults (3). The pathology of MIS-C/A and its relationship to SARS-CoV-2 infection are not yet known.
No takes yet. Share an insight, caveat, or question.
Weatherhead et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: